Eco Animal Health Group (FRA:LWA) Short-Term Debt: €0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LWA Eco Animal Health Group PLC FRA:LWA
55 GF Score
Price €0.99
GF Value €1.13
! 3 Warning Signs
View Full Analysis

What is Eco Animal Health Group Short-Term Debt?

Eco Animal Health Group FRA:LWA 55 Short-Term Debt is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:LWA with a GF Score™ of 55/100 and a GF Value™ of €1.13. The stock has 3 warning signs investors should review.

Eco Animal Health Group's Short-Term Debt for the quarter that ended in Mar. 2026 was €0.0 Mil.

Eco Animal Health Group Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Eco Animal Health Group Short-Term Debt Related Terms

Eco Animal Health Group Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Eco Animal Health Group's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eco Animal Health Group Short-Term Debt Chart

Eco Animal Health Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Eco Animal Health Group Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:LWA
55GF Score
Eco Animal Health Group PLC FRA:LWA
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €0.0 Mil mean?
Eco Animal Health Group (FRA:LWA) has a Short-Term Debt of €0.0 Mil as of Mar. 2026.
Is Eco Animal Health Group's Short-Term Debt too high?
Eco Animal Health Group's current Short-Term Debt is €0.0 Mil. Overall, Eco Animal Health Group has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Eco Animal Health Group's Short-Term Debt compare to ZTS and UTHR?
Eco Animal Health Group's Short-Term Debt of €0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Eco Animal Health Group's current Short-Term Debt is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eco Animal Health Group stock overvalued right now?
Eco Animal Health Group (FRA:LWA) has a current Short-Term Debt of €0.0 Mil. The stock's GF Value™ is €1.13, compared to a current price of €0.99 — trading 12.4% below its estimated fair value. The current Short-Term Debt is €0.0 Mil. Eco Animal Health Group's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Eco Animal Health Group (FRA:LWA), the current Short-Term Debt is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eco Animal Health Group (FRA:LWA) Overvalued in 2026?

Based on GuruFocus' analysis, Eco Animal Health Group stock appears to be undervalued. The current stock price of €0.99 is trading 12.4% below its estimated GF Value™ of €1.13.

Key valuation signals for FRA:LWA:

  • Short-Term Debt: €0.0 Mil
  • GF Value™: €1.13 vs. price of €0.99 (12.4% below fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the FRA:LWA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eco Animal Health Group Business Description

Other Exchanges EAH:UKLWA:Germany
Address 100 High street, The Grange, Southgate, London, GBR, N14 6BN
Eco Animal Health Group PLC is an animal health biotech company. It provides quality products for swine and poultry, anti-infectives to treat illness, improve health, and performance. Its products include Aivlosin/Valosin Solutions and Parasite Solutions. The company's segments include Corporate/UK, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World, with the majority of the revenue deriving from China and Japan.
55GF Score

Get the complete analysis for FRA:LWA

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.99
Price
€1.13
GF Value